Viridian Therapeutics
Price & Volume
Stats
See more52W Range | $9.90-$27.20 |
Market Cap | $1.6B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $305,000 |
Revenue Growth (YoY) | 4.2% |
Gross Profit (12 Mos) | -$304.2M |
Diluted EPS | -$3.57 |
News
See moreYahoo Finance • 2 months ago
Viridian licenses thyroid eye disease treatments to Kissei in Japan
Yahoo Finance • 4 months ago
Viridian Therapeutics' SWOT analysis: promising TED treatment stock faces pivotal year
Yahoo Finance • 2 years ago
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
Yahoo Finance • 2 years ago
Viridian Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
About
CEO | Mr. Stephen F. Mahoney J.D., MBA |
Address | 221 Crescent Street, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 143 |
